Skip to main navigation
About
News & Events
News Releases
Events
Annual Meeting
Results
Stock Information
Stock Quote & Chart
Analyst Coverage
Regulated Information
Governance
Governance Documents
Management
Board of Directors
Whistleblower
IR Resources
Investor FAQs
Contact IR
Email Alerts
About
News Releases
Events
Annual Meeting
Results
Stock Quote & Chart
Analyst Coverage
Regulated Information
Governance Documents
Management
Board of Directors
Whistleblower
Investor FAQs
Contact IR
Email Alerts

News Releases

Obagi Medical and Next Health Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
Next Health selected as a leading wellness and longevity partner given its innovative approach to personalized aesthetics and health optimization NEW YORK and LOS ANGELES, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions
January 28, 2026
Obagi Medical and Alpha Aesthetic Partners Announce Their Collaboration in the ALOHA Program to Drive Real-World Evidence with Obagi® saypha® MagIQ™
Alpha selected as the first Medspa platform partner given their commitment to innovation, education, and breaking through barriers NEW YORK and SACRAMENTO, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part
January 27, 2026
Obagi Medical and Platinum Dermatology Partners Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
Platinum selected as the first dermatology platform partner due to its commitment to clinical evidence and dissemination across its network of practices NEW YORK and DALLAS, Jan. 26, 2026 (GLOBE NEWSWIRE) -- Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions
January 26, 2026
Obagi Medical Unveils ALOHA Program to Launch Obagi® saypha® MagIQ™ – Pioneering the Largest Real-World Evaluation of a New Hyaluronic Acid Filler
Program Designed to Drive Real World, Practice Focused Evidence with Injectables & Skincare NEW YORK, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of Waldencast plc (NASDAQ: WALD) (“Waldencast” or the
January 21, 2026
  • First page «
  • Previous page ‹
  • Page 1
  • Current page 2
Displaying 11 - 14 of 14

contact investor relations

Investors
ICR

Allison Malkin

waldencastir@icrinc.com

Media
ICR

Brittany Fraser

waldencastir@icrinc.com

Subscribe for updates

About
Our Brands
Newsroom
Investors
Contact
Cookie Policy
Privacy Policy
Waldencast Ventures